Exchange: TSXV·Updated 02:16 PM EDT

APLI.TSXV Appili Therapeutics Inc - Ordinary Shares - Class A

$0.005
$0.005
(50.00%)
Today
Mkt Cap$1.32M
Vol117,001.00

About APLI.TSXV

Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
50

Sentiment

How do you feel about APLI.TSXV?

Advertisement|Remove ads.